{{insights.date}}
{{insights.type}}
{{insights.contentTypeTag}}
Danielle is a partner in the Global Corporate Practice Group with a focus on matters involving private equity and M&A. She advises private equity sponsors throughout the life cycle of their investments – from the platform company acquisition to the ultimate exit. Danielle represents private equity sponsors that invest in life sciences, healthtech, bioanalytical products, testing and certification services and specialty business products industries.
Private equity clients turn to Danielle to structure, negotiate and close complex domestic and cross-border mergers and acquisitions, leveraged buyouts and auctions. Danielle also advises portfolio companies with add-on acquisitions, recapitalizations, equity financings, exit preparation, regulatory compliance, corporate governance and management incentive plans.
Danielle has been recognized in The Best Lawyers in America for Mergers and Acquisitions Law since 2023. She is an adjunct professor at Case Western Reserve University’s School of Law, where she teaches international business transactions, and has served on Law360’s Editorial Advisory Board for Private Equity.
- Represented a private equity firm with its platform and add-on acquisitions of multi-state home care and home health services agencies.
- Represented a private equity firm with its acquisition of a contract research organization and add-on acquisition of a provider of bioanalytical services.
- Represented a private equity firm with its acquisition of an international manufacturer of analytical instruments for particle, and materials characterization and subsequent implementation of a compliance framework for worldwide operations.
- Represented a private equity firm with its acquisition of a manufacturer of laboratory equipment used in drug development and add-on acquisition of a provider of laboratory safety solutions.
- Represented a private equity firm with its acquisition of a manufacturer of analytical instrumentation for formulation development and quality control.
- Represented a private equity firm with its acquisition of a provider of vision-based analytical solutions.
- Represented a private equity firm with its acquisition of a provider of inspection and maintenance repair services for industrial, refining, chemical and offshore applications.
- Represented a private equity firm with its acquisition of a provider of measurement testing, calibration and consulting services.
- Represented a private equity firm with its sale of an international manufacturer of automated inspection technology solutions.
- Represented a private equity firm with its sale of a national provider of respiratory equipment and logistics services.
- Represented a private equity firm with its sale of developers, manufacturers and distributors of specialty cleaning products.
- Represented a private equity firm with its acquisition of a provider of molding and machining services.
- Represented a private equity firm with its acquisition of a manufacturer and distributor of electronic components.
- Represented a private equity firm with its acquisition of a manufacturer of high-temperature and fire-resistant wire and cable.
Education
- University of Detroit Mercy, J.D., summa cum laude
- American University of Beirut, M.B.A.
- Case Western Reserve University, B.A.
Admissions
- New York
- Ohio
Languages
- English
- Arabic
- Recognized in The Best Lawyers in America 2023-2025 for Mergers and Acquisitions Law.
- Co-Author, “SEC’s New Rules Impact the Regulation of Private Fund Advisers,” October 2023.
- Co-Author, “Update to Main Street Lending Program,” June 2020.
- Quoted, “Fed’s Coronavirus Stimulus Offers Taxpayer Cash to Buyout Firm Companies,” The Wall Street Journal, April 16, 2020.
- Co-Author, “Main Street Lending Program: Considerations for Private Equity Sponsors,” April 2020.
- Quoted, “Private Equity Steps Up Push to Unlock Coronavirus Stimulus,” The Wall Street Journal, April 1, 2020.
- Quoted, “Senate’s Coronavirus Stimulus Deal Offers Little Relief for Private Equity,” The Wall Street Journal, March 25, 2020.
- Co-Author, “Existing Restrictions May Preclude PE-Backed Small Companies From Getting Relief Under The COVID-19 Stimulus Bill,” March 2020.
- Presenter, “New Proposed HSR Changes and the Impact on Private Equity: Intensified Scrutiny, Increased Reporting Requirements,” Strafford webinar, November 21, 2023.
- Presenter, “Equity Rollovers in M&A Transactions: Negotiating and Structuring Rollovers, Tax Considerations for Buyers and Sellers,” Strafford webinar, September 20, 2023. With encore presentations on December 21, 2023 and March 25, 2024.
- Presenter, “Private Equity M&A Key Deal Terms in a Changing Market,” Strafford webinar, February 4, 2021.
- Presenter, “2021: Looking Ahead to a Post-elections World – Implications for the Healthcare and Life Sciences Sectors,” January 11, 2021.
- Presenter, “Opportunity and Adversity in the Funding Landscape,” Venture Law webinar, July 31, 2020.
- Presenter, “The Impact of Private Equity Ownership of Providers on Managed Care,” American Conference Institute’s Managed Care Disputes and Litigation Conference, July 22, 2020.
- Presenter, “Small Business Administration Loans under the America CARES Act,” Venture Law webinar, April 3, 2020.
- Presenter, “Understanding Venture Capital Term Sheets,” Venture Law webinar, February 14, 2020.
- Presenter, “M&A Buyer Protection Provisions in Private M&A Purchase Agreements Beyond Indemnification for Breaches of Representations and Warranties – Purchase Price Adjustments, Contingent Payments, Accounts Receivable Repurchase, Inventory Audit, Retained Liabilities,” Strafford webinar, November 21, 2019.
- Presenter, “Private Equity M&A Key Deal Terms: Rollover Equity, Bolt-On, Tuck-In and Platform Acquisitions, Earnouts and More,” Strafford webinar, September 5, 2019.